[ad_1]
A COVID-19 vaccine developed by a Beijing firm linked to Sinopharm has a protection rate of 79.34 percent against the disease, the firm said in a statement on Wednesday.
Beijing Biological Products Institute Co. Ltd said it had applied to the National Medical Products Administration for conditional approval of the vaccine.
For more coronavirus news, visit our dedicated page.
The result is based on interim analysis of data from its Phase III clinical trial, but the firm did not give details such as the number of infections in the trial.
Read more:
Coronavirus: Dubai aims to inoculate 70 pct of population with Pfizer vaccine in 2021
Coronavirus: Where are we in the COVID-19 vaccine race?
Coronavirus: 5,000 people a day to receive free Sinopharm vaccine in Abu Dhabi
SHOW MORE
Last Update: Wednesday, 30 December 2020 KSA 07:57 – GMT 04:57
[ad_2]
Source link
